IMARC Group has recently released a report titled “Carotid Artery Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033” that presents a comprehensive assessment of the carotid artery disease market size, latest trends, and growth forecast. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the global market. The report also highlights key segments and market drivers, as well as challenges faced by industry players.
Carotid artery disease, also known as carotid artery stenosis, occurs when the carotid arteries, which supply oxygenated blood to the brain, become narrowed or blocked. The most common symptom is transient ischemic attacks, characterized by temporary episodes of neurological dysfunction, including vision changes, numbness, slurred speech, etc. Several other indications include sudden and severe headaches, dizziness, confusion, facial drooping, difficulty with coordination, etc. Diagnosing the ailment typically involves a combination of medical history assessment, physical examination, and diagnostic tests.
Request a Free Sample Report: https://www.imarcgroup.com/carotid-artery-disease-market/requestsample
Market Trend:
The elevating prevalence of atherosclerosis, which is characterized by the accumulation of plaque in the artery walls, thereby resulting in the narrowing of the carotid arteries, is primarily augmenting the carotid artery disease market. Additionally, the increasing incidence of several risk factors, such as obesity, hypertension, diabetes, and certain inflammatory conditions like rheumatoid arthritis, etc., is further catalyzing the market growth. Besides this, the rising utilization of antiplatelet drugs, including clopidogrel and ticagrelor, for minimizing the likelihood of blood clot formation in the carotid arteries is acting as another significant growth-inducing factor. Furthermore, the inflating usage of carotid endarterectomy, which involves making an incision in the neck, accessing the affected artery, and removing the plaque to restore blood flow, in patients at high risk for stroke, is also contributing to the market growth. Apart from this, the introduction of transcarotid artery revascularization and transradial carotid artery stenting, which are less invasive with a reduced likelihood of complications, is projected to fuel the carotid artery disease market over the forecasted period.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the carotid artery disease market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the carotid artery disease market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/carotid-artery-disease-market
Key Questions Answered in this Report:
- How has the carotid artery disease market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the carotid artery disease market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the carotid artery disease market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Spinal Muscular Atrophy Market Report 2023-2033
Acalculous Cholecystitis Market Report 2023-2033
Tourette Syndrome Market Report 2023-2033
Status Epilepticus Market Report 2023-2033
Significant Benefits of the Report to Stakeholders:
- Individuals directly or indirectly involved in the value chain of the carotid artery disease market can gain valuable insights into key players and major market trends, enabling them to stay up-to-date and make informed decisions.
- Professionals responsible for selecting a carotid artery disease market for large and enterprise-level organizations can conduct thorough due diligence by leveraging the comprehensive information provided in this report.
- Those seeking current intelligence on the dynamic carotid artery disease market can benefit from the report’s valuable insights, helping them stay informed and make strategic business decisions.
- Companies operating in the carotid artery disease market can benchmark and assess their market position and standing against their competitors, gaining a strategic viewpoint to evaluate and adapt to the changing market landscape.
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
